BACKGROUND: We aimed to describe clinico-pathological characteristics and differences between right-sided (RCC) and left-sided colon cancer (LCC) in Tunisian population. We also analyzed outcome to determine whether location is of prognostic significance. METHODS: Clinico-pathological characteristics and Kaplan Meier survival were compared between two groups of LCC [150] and RCC [53] patients with stage II and III adenocarcinoma treated with curative intent between 2003-2014. RESULTS: RCC patients were significantly more likely to be female, (56.6% vs. 39.3%, P=0.029) and to have undifferentiated tumor (87.1% vs. 8.4%, P=0.014), then LCC. After a median follow up of 49 months, 5-year overall survival (OS) was significantly worse in RCC vs. LCC [42% vs. 78%; hazard ratio (HR) =2.07; 95% CI: 1.05-4.09; P=0.03], no difference in relapse free survival (RFS) was observed. Median time to relapse was significantly shorter in RCC (15 months) vs. LCC (24 months), P=0.005. Tumor location significantly impacted survival in stage III, 5-year OS was 45% in RCC, and 63% in LCC, (HR =2.28; 95% CI: 1.01-5.24; P=0.04), there was no impact of tumor location in stage II, (HR =1.94; 95% CI: 0.54-6.93; P=0.29). CONCLUSIONS: Prognostic impact of tumor location should be considered as a stratification factor in the future clinical trials.
BACKGROUND: We aimed to describe clinico-pathological characteristics and differences between right-sided (RCC) and left-sided colon cancer (LCC) in Tunisian population. We also analyzed outcome to determine whether location is of prognostic significance. METHODS: Clinico-pathological characteristics and Kaplan Meier survival were compared between two groups of LCC [150] and RCC [53] patients with stage II and III adenocarcinoma treated with curative intent between 2003-2014. RESULTS: RCC patients were significantly more likely to be female, (56.6% vs. 39.3%, P=0.029) and to have undifferentiated tumor (87.1% vs. 8.4%, P=0.014), then LCC. After a median follow up of 49 months, 5-year overall survival (OS) was significantly worse in RCC vs. LCC [42% vs. 78%; hazard ratio (HR) =2.07; 95% CI: 1.05-4.09; P=0.03], no difference in relapse free survival (RFS) was observed. Median time to relapse was significantly shorter in RCC (15 months) vs. LCC (24 months), P=0.005. Tumor location significantly impacted survival in stage III, 5-year OS was 45% in RCC, and 63% in LCC, (HR =2.28; 95% CI: 1.01-5.24; P=0.04), there was no impact of tumor location in stage II, (HR =1.94; 95% CI: 0.54-6.93; P=0.29). CONCLUSIONS: Prognostic impact of tumor location should be considered as a stratification factor in the future clinical trials.
Entities:
Keywords:
Colon cancer (CC); adjuvant therapy; anatomic side; early stage; survival
Authors: Frank A Sinicrope; Michelle R Mahoney; Thomas C Smyrk; Stephen N Thibodeau; Robert S Warren; Monica M Bertagnolli; Garth D Nelson; Richard M Goldberg; Daniel J Sargent; Steven R Alberts Journal: J Clin Oncol Date: 2013-09-09 Impact factor: 44.544
Authors: Julian Walter Holch; Ingrid Ricard; Sebastian Stintzing; Dominik Paul Modest; Volker Heinemann Journal: Eur J Cancer Date: 2016-11-29 Impact factor: 9.162
Authors: Hui-Li Wong; Belinda Lee; Kathryn Field; Anna Lomax; Mark Tacey; Jeremy Shapiro; Joe McKendrick; Allan Zimet; Desmond Yip; Louise Nott; Ross Jennens; Gary Richardson; Jeanne Tie; Suzanne Kosmider; Phillip Parente; Lionel Lim; Prasad Cooray; Ben Tran; Jayesh Desai; Rachel Wong; Peter Gibbs Journal: Clin Colorectal Cancer Date: 2016-02-13 Impact factor: 4.481
Authors: Michael Bretthauer; Michal F Kaminski; Magnus Løberg; Ann G Zauber; Jaroslaw Regula; Ernst J Kuipers; Miguel A Hernán; Eleanor McFadden; Annike Sunde; Mette Kalager; Evelien Dekker; Iris Lansdorp-Vogelaar; Kjetil Garborg; Maciej Rupinski; Manon C W Spaander; Marek Bugajski; Ole Høie; Tryggvi Stefansson; Geir Hoff; Hans-Olov Adami Journal: JAMA Intern Med Date: 2016-07-01 Impact factor: 21.873
Authors: Rene Warschkow; Michael C Sulz; Lukas Marti; Ignazio Tarantino; Bruno M Schmied; Thomas Cerny; Ulrich Güller Journal: BMC Cancer Date: 2016-07-28 Impact factor: 4.430
Authors: Claudius E Degro; Richard Strozynski; Florian N Loch; Christian Schineis; Fiona Speichinger; Lucas D Lee; Georgios A Margonis; Johannes C Lauscher; Katharina Beyer; Martin E Kreis; Carsten Kamphues Journal: Int J Colorectal Dis Date: 2021-08-26 Impact factor: 2.571